I’ve lost count of the number of times I’ve seen organisations celebrate reaching a major product milestone and assume the hardest work is behind them.
Regulatory approval has been achieved.
Product development is complete.
Marketing materials are ready.
Launch plans are underway.
Yet many of the most important factors influencing commercial success are only just beginning to emerge.
In healthcare, launch readiness and market readiness are not always the same thing.
A product can be technically ready for market while still facing significant adoption challenges.
Healthcare organisations often invest years developing products.
As a result, internal teams naturally focus on technical development, validation and regulatory milestones.
These are critical activities.
However, customers typically evaluate products very differently.
Healthcare stakeholders rarely ask:
“How difficult was this product to develop?”
They ask:
Successful launches require organisations to shift attention from product readiness to customer readiness.
One of the most common commercial mistakes is oversimplifying the decision-making process.
Healthcare purchasing decisions often involve multiple stakeholders with different priorities.
Clinicians may focus on outcomes.
Procurement teams may focus on risk and supplier considerations.
Finance teams may focus on cost.
Executives may focus on organisational priorities.
A launch strategy that resonates with one audience may fail to resonate with others.
Understanding these differences early creates stronger commercial foundations.
A product may deliver excellent clinical outcomes.
That alone does not guarantee adoption.
Different stakeholder groups often define value differently.
Clinical teams may focus on patient outcomes.
Operational teams may focus on workflow efficiency.
Management teams may focus on resource utilisation.
Finance teams may focus on economic impact.
Strong healthcare product launches communicate value across multiple dimensions rather than relying on a single message.
Healthcare organisations frequently discuss evidence generation.
The challenge is not simply generating evidence.
The challenge is generating evidence that helps stakeholders make decisions.
In my experience, organisations often focus heavily on proving that a product works while giving less attention to demonstrating why it should be adopted.
Healthcare decision makers increasingly want to understand:
A launch strategy should anticipate these questions long before they are asked.
Launch plans often focus on awareness activities.
Presentations.
Marketing campaigns.
Conference activity.
Product demonstrations.
These activities are important, but awareness and adoption are not the same thing.
Adoption requires change.
People may need training.
Processes may need updating.
Workflows may need adapting.
The strongest healthcare commercialisation strategies recognise that implementation support can be just as important as product promotion.
Products launch more effectively when product, marketing and commercial teams work from a shared understanding of the market.
Misalignment often creates problems such as:
Alignment helps ensure that launch activities support broader commercial objectives rather than becoming isolated projects.
Many organisations treat launch as the destination.
In reality, it is usually the beginning.
The first six to twelve months after launch often provide the most valuable commercial insights.
Questions start to emerge:
Organisations that listen carefully during this period are often better positioned to accelerate growth.
One observation I’ve made repeatedly throughout healthcare and MedTech is that commercial outcomes are often shaped long before launch day arrives.
The strongest product launches are rarely the result of a brilliant campaign or a successful conference.
More often, they are the result of months or years of thoughtful preparation.
Customer understanding.
Stakeholder engagement.
Evidence generation.
Adoption planning.
Commercial alignment.
By the time the product launches, many of the foundations for success are already in place.
A successful healthcare product launch involves far more than making a product available to the market.
Commercial success depends on understanding stakeholders, anticipating adoption challenges and demonstrating value in ways that matter to decision makers.
The organisations that consistently launch successfully are rarely those with the best launch event.
They are usually those with the strongest understanding of what happens after the launch.
Before asking:
“Are we ready to launch?”
it is often worth asking:
“Is the market ready to adopt what we’re launching?”